Correlation Between Morgan Stanley and PharmChem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and PharmChem, you can compare the effects of market volatilities on Morgan Stanley and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and PharmChem.

Diversification Opportunities for Morgan Stanley and PharmChem

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Morgan and PharmChem is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and PharmChem go up and down completely randomly.

Pair Corralation between Morgan Stanley and PharmChem

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.31 times more return on investment than PharmChem. However, Morgan Stanley Direct is 3.24 times less risky than PharmChem. It trades about 0.14 of its potential returns per unit of risk. PharmChem is currently generating about -0.08 per unit of risk. If you would invest  1,957  in Morgan Stanley Direct on September 18, 2024 and sell it today you would earn a total of  167.00  from holding Morgan Stanley Direct or generate 8.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.41%
ValuesDaily Returns

Morgan Stanley Direct  vs.  PharmChem

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
PharmChem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Morgan Stanley and PharmChem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and PharmChem

The main advantage of trading using opposite Morgan Stanley and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.
The idea behind Morgan Stanley Direct and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like